TRAITEMENT DES MALADIES ASSOCIÉES AU FACTEUR DE CROISSANCE DU FIBROBLASTE 21 (FGF21) PAR L'INHIBITION D'UN PRODUIT DE LA TRANSCRIPTION ANTISENS NATUREL DE FGF21

• 收藏
• 分享

专利权人:

INC.;CURNA

发明人:

COLLARD, JOSEPH,KHORKOVA SHERMAN, OLGA

申请号：

EP11766771

公开号：

EP2556160A4

申请日:

2011.04.08

申请国别(地区):

EP

年份:

2013

代理人:

摘要：

The present invention relates to antisense oligonucleotides that modulate the expression of and/or function of Fibroblast growth factor 21 (FGF21), in particular, by targeting natural antisense polynucleotides of Fibroblast growth factor 21 (FGF21). The invention also relates to the identification of these antisense oligonucleotides and their use in treating diseases and disorders associated with expression of FGF21.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/